Published in Ann Clin Microbiol Antimicrob on January 11, 2012
Integrating "omics" Technologies to Conceptualize Dynamic Antimicrobial Peptide Responses. Front Immunol (2012) 0.77
The therapeutic potential of medicinal foods. Adv Pharmacol Sci (2014) 0.76
Reciprocal immune benefit based on complementary production of antibiotics by the leech Hirudo verbana and its gut symbiont Aeromonas veronii. Sci Rep (2015) 0.76
Guardians of the Gut: Enteric Defensins. Front Microbiol (2017) 0.75
Studies on the interaction of tumor-derived HD5 alpha defensins with adenoviruses and implications for oncolytic adenovirus therapy. J Virol (2017) 0.75
Quantitative metaproteomics and activity-based probe enrichment reveals significant alterations in protein expression from a mouse model of inflammatory bowel disease. J Proteome Res (2017) 0.75
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 6.49
Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature (2011) 5.45
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science (2000) 5.38
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 5.14
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta (1999) 4.71
Interconversion between intestinal stem cell populations in distinct niches. Science (2011) 4.23
Nod2 is essential for temporal development of intestinal microbial communities. Gut (2011) 3.69
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13
Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development (2005) 2.56
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol (2007) 2.28
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol (2011) 2.21
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol (1998) 2.19
Mouse neutrophils lack defensins. Infect Immun (1992) 2.01
Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics (2005) 1.97
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut (2010) 1.77
The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol (2007) 1.73
Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun (2003) 1.69
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol (2010) 1.62
Structure and diversity of the murine cryptdin gene family. Genomics (1994) 1.62
Antimicrobial specificity of leukocyte lysosomal cationic proteins. Science (1966) 1.58
Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett (2006) 1.44
TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. J Biol Chem (2010) 1.31
Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci (2001) 1.29
Stem cell self-renewal in intestinal crypt. Exp Cell Res (2011) 1.26
Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol (2009) 1.24
A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol (2007) 1.23
Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol (2007) 1.20
Human defensins as cancer biomarkers and antitumour molecules. J Proteomics (2009) 1.20
Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol (2004) 1.18
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci U S A (1997) 1.08
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One (2011) 1.08
Structure-dependent functional properties of human defensin 5. FEBS Lett (2007) 1.07
Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol (2008) 1.07
Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda) (2008) 1.06
Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol (2008) 1.05
The changing of the guard: Molecular diversity and rapid evolution of beta-defensins. Mol Divers (2006) 1.03
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Defensins: natural anti-HIV peptides. AIDS Rev (2004) 0.99
TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. J Immunol (2010) 0.99
The innate immune system in the intestine. Microbiol Immunol (2010) 0.98
Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J Biol Chem (2004) 0.96
Microbiology. How to get along--friendly microbes in a hostile world. Science (2000) 0.96
Peptide localization and gene structure of cryptdin 4, a differentially expressed mouse paneth cell alpha-defensin. Infect Immun (1999) 0.96
Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm Bowel Dis (2009) 0.94
Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome. BMC Genomics (2009) 0.93
Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway. Hum Pathol (2009) 0.91
Postnatal changes in the expression of genes for cryptdins 1-6 and the role of luminal bacteria in cryptdin gene expression in mouse small intestine. FEMS Immunol Med Microbiol (2008) 0.89
Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol (2004) 0.87
A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci (2006) 0.86
Precursor processing of human defensin-5 is essential to the multiple functions in vitro and in vivo. J Innate Immun (2009) 0.82
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis. Dig Liver Dis (2010) 0.78
Defensins keep the peace too. Nat Immunol (2010) 0.78
Defensin alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients. BMC Cancer (2010) 0.76
Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain. Immunity (2009) 1.98
Cytotoxic T lymphocytes form an antigen-independent ring junction. J Clin Invest (2004) 1.72
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response. Proc Natl Acad Sci U S A (2006) 1.58
ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol (2005) 1.55
Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (2005) 1.51
Protein kinase C theta regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL. J Immunol (2008) 1.24
Distinct molecular mechanisms account for the specificity of two different T-cell receptors. Biochemistry (2003) 1.12
Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer. BMC Cancer (2010) 1.11
Differential expression of CHL1 gene during development of major human cancers. PLoS One (2011) 1.06
Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics (2012) 1.03
Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells. Proc Natl Acad Sci U S A (2008) 0.99
How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide. J Biol Chem (2008) 0.96
Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes. J Biol Chem (2006) 0.96
Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like? J Biol Chem (2004) 0.94
Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes. Immunology (2004) 0.90
Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells? Clin Immunol (2008) 0.89
Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes. Immunol Res (2011) 0.89
Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling. PLoS One (2012) 0.88
Soluble HIV-specific T cell receptor: expression, purification and analysis of the specificity. J Immunol Methods (2003) 0.87
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope. Mol Immunol (2005) 0.84
Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer. Pathol Oncol Res (2014) 0.83
NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer. Int J Mol Sci (2012) 0.82
Tissue-specific alternative splicing analysis reveals the diversity of chromosome 18 transcriptome. J Proteome Res (2013) 0.79
Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. Eur J Immunol (2014) 0.78
A novel composite immunotoxin that suppresses rabies virus production by the infected cells. J Immunol Methods (2009) 0.78
Differential splicing generates Tvl-1/RFXANK isoforms with different functions. J Biol Chem (2002) 0.77
Expression of cyclophilin A in gastric adenocarcinoma patients and its inverse association with local relapses and distant metastasis. Pathol Oncol Res (2013) 0.76